Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized trial

Atherosclerosis

Volumn 246, Issue , 2016, Pages 169-176

  Mullan, Adam ^a   Delles, Christian ^a   Ferrell, William ^a   Mullen, William ^a   Edwards, Christine A ^a   McColl, John H ^a   Roberts, Susan A ^b   Lean, Michael E ^a   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b The Coca Cola Company   (United States)

Author keywords

Aortic augmentation index; Cardiovascular risk; Flavonoids; HydroxyCinnamates; Iontophoresis; Obesity; Overweight; Pulse wave velocity; Vascular function

Indexed keywords

ACETYLCHOLINE; ADIPONECTIN; APOLIPOPROTEIN; ASCORBIC ACID; C REACTIVE PROTEIN; COUMARIC ACID; CYSTATIN C; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLAVONOID; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; NITROPRUSSIDE SODIUM; PLACEBO; POLYPHENOL DERIVATIVE; BIOLOGICAL MARKER; POLYPHENOL;

ADULT; ARTICLE; BEVERAGE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; HUMAN; IONTOPHORESIS; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE; ADVERSE EFFECTS; AGED; ARTERIAL STIFFNESS; BLOOD; COMPLICATION; DRUG EFFECTS; FEMALE; FRUIT AND VEGETABLE JUICE; HEMODYNAMICS; MALE; MICROCIRCULATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PILOT STUDY; RISK FACTOR; SCOTLAND; SKIN; TIME FACTOR; TREATMENT OUTCOME; VASCULAR DISEASES; VASCULAR RESISTANCE; VASCULARIZATION; VASODILATATION;

ADMINISTRATION, ORAL; AGED; BIOMARKERS; COUMARIC ACIDS; FEMALE; FLAVONOIDS; FRUIT AND VEGETABLE JUICES; HEMODYNAMICS; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; OBESITY; PILOT PROJECTS; POLYPHENOLS; PULSE WAVE ANALYSIS; RISK FACTORS; SCOTLAND; SKIN; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES; VASCULAR RESISTANCE; VASCULAR STIFFNESS; VASODILATION;

EID: 84955593144     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.01.004     Document Type: Article

References (37)

1. He F.J., Nowson C.A., Lucas M., MacGregor G.A. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J. Hum. Hypertens. 2007, 21:717-728.
2. Dauchet L., Amouyel P., Hercberg S., Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J. Nutr. 2006, 136:2588-2593.
3. Joshipura K.J., Hu F.B., Manson J.E., Stampfer M.J., Rimm E.B., Speizer F.E., Colditz G., Ascherio A., Rosner B., Spiegelman D., et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern Med. 2001, 134:1106-1114.
4. Nagura J., Iso H., Watanabe Y., Maruyama K., Date C., Toyoshima H., Yamamoto A., Kikuchi S., Koizumi A., Kondo T., et al. Fruit, vegetable and bean intake and mortality from cardiovascular disease among Japanese men and women: the JACC study. Br. J. Nutr. 2009, 102:285-292.
5. Crowe F., Roddam A., Key T., Appleby P., Overvad K., Jakobsen M., Tjønneland A., Hansen L., Boeing H., Weikert C., et al. Fruit and vegetable intake and mortality from ischaemic heart disease: results from the european prospective investigation into Cancer and nutrition (EPIC)-Heart study. Eur. Heart J. 2011, 32:1235-1243.
6. Bazzano L.A. Dietary Intake of Fruits and Vegetables and Risk of Diabetes Mellitus and Cardiovacular Disease 2005, World Health Organisation, Geneva.
7. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., Dallongeville J., De Backer G., Ebrahim S., Gjelsvik B., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14(Suppl. 2):S1-S113.
8. Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Houston Miller N., Hubbard V.S., Lee I.M., Lichtenstein A.H., Loria C.M., Millen B.E., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the american college of cardiology/american heart association task force on practice Guidelines. J. Am. Coll. Cardiol. 2014, 63:2960-2984.
9. Del Rio D., Rodriguez-Mateos A., Spencer J.P., Tognolini M., Borges G., Crozier A. Dietary (Poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal 2013, 18(14):1818-1892.
10. Welsh P., Packard C.J., Sattar N. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Curr. Opin. Lipidol. 2008, 19:563-571.
11. Borges G., Mullen W., Mullan A., Lean M.E., Roberts S.A., Crozier A. Bioavailability of multiple components following acute ingestion of a polyphenol-rich juice drink. Mol. Nutr. Food Res. 2010, 54:S268-S277.
12. Ramsay J.E., Simms R.J., Ferrell W.R., Crawford L., Greer I.A., Lumsden M.A., Sattar N. Enhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetes. Diabetes Care 2003, 26:475-479.
13. Jadhav S., Ferrell W., Greer I.A., Petrie J.R., Cobbe S.M., Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol. 2006, 48:956-963.
14. Vlachopoulos C., Aznaouridis K., Alexopoulos N., Economou E., Andreadou I., Stefanadis C. Effect of dark chocolate on arterial function in healthy individuals. Am. J. Hypertens. 2005, 18:785-791.
15. Fisher N.D., Hollenberg N.K. Aging and vascular responses to flavanol-rich cocoa. J. Hypertens. 2006, 24:1575-1580.
16. Faridi Z., Njike V.Y., Dutta S., Ali A., Katz D.L. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am. J. Clin. Nutr. 2008, 88:58-63.
17. Jadhav S., Sattar N., Petrie J.R., Cobbe S.M., Ferrell W.R. Reproducibility and repeatability of peripheral microvascular assessment using iontophoresis in conjunction with laser doppler imaging. J. Cardiovasc. Pharmacol. 2007, 50:343-349.
18. Pickering T.G., Hall J.E., Appel L.J., Falkner B.E., Graves J., Hill M.N., Jones D.W., Kurtz T., Sheps S.G., Roccella E.J. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association Council on high blood pressure Research. Circulation 2005, 111:697-716.
19. McConway M.G., Johnson D., Kelly A., Griffin D., Smith J., Wallace A.M. Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Ann. Clin. Biochem. 2000, 37:717-723.
20. Ramsay J.E., Ferrell W.R., Greer I.A., Sattar N. Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J. Cardiovasc Pharmacol. 2002, 39:9-17.
21. Ferrell W.R., Ramsay J.E., Brooks N., Lockhart J.C., Dickson S., McNeece G.M., Greer I.A., Sattar N. Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. J. Vasc. Res. 2002, 39:447-455.
22. Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, Hingorani A.D., Casas J.P. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012, 379:1214-1224.
23. Peeters A., Barendregt J.J., Willekens F., Mackenbach J.P., Al Mamun A., Bonneux L. NEDCOM,the Netherlands epidemiology and demography compression of morbidity research group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern Med. 2003, 138:24-32.
24. Chan Y.H., Lau K.K., Yiu K.H., Li S.W., Chan H.T., Fong D.Y., Tam S., Lau C.P., Tse H.F. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur. Heart J. 2008, 29:2800-2807.
25. Duffy S.J., Keaney J.F., Holbrook M., Gokce N., Swerdloff P.L., Frei B., Vita J.A. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104:151-156.
26. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999, 100:1050-1055.
27. Nagao T., Hase T., Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 2007, 15:1473-1483.
28. Ward N.C., Hodgson J.M., Croft K.D., Burke V., Beilin L.J., Puddey I.B. The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J. Hypertens. 2005, 23:427-434.
29. van den Elzen A.P., Sierksma A., Oren A., Vos L.E., Witteman J.C., Grobbee D.E., Hendriks H.F., Uiterwaal C.S., Bots M.L. Alcohol intake and aortic stiffness in young men and women. J. Hypertens. 2005, 23:731-735.
30. Matsumoto C., Tomiyama H., Yamada J., Yoshida M., Shiina K., Nagata M., Yamashina A. Association of blood pressure levels with the effects of alcohol intake on the vasculature in Japanese men. Hypertens. Res. Clin. Exp. 2009, 32:127-132.
31. Plotnick G.D., Corretti M.C., Vogel R.A., Hesslink R., Wise J.A. Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal. J. Am. Coll. Cardiol. 2003, 41:1744-1749.
32. Tresserra-Rimbau A., Rimm E.B., Medina-Remon A., Martinez-Gonzalez M.A., de la Torre R., Corella D., Salas-Salvado J., Gomez-Gracia E., Lapetra J., Aros F., et al. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr. Metab.Cardiovasc. Dis. 2014, 24:639-647.
33. Frank J., George T.W., Lodge J.K., Rodriguez-Mateos A.M., Spencer J.P., Minihane A.M., Rimbach G. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J. Nutr. 2009, 139:58-62.
34. Mullen W., Gonzalez J., Siwy J., Franke J., Sattar N., Mullan A., Roberts S., Delles C., Mischak H., Albalat A. A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. J. Agric. Food Chem. 2011, 59:12850-12857.
35. Silva S., Bronze M.R., Figueira M.E., Siwy J., Mischak H., Combet E., Mullen W. Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study. Am. J. Clin. Nutr. 2015, 101:44-54.
36. Buijsse B., Feskens E.J., Kok F.J., Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the zutphen elderly Study. Arch. Intern Med. 2006, 166:411-417.
37. Flammer A.J., Hermann F., Sudano I., Spieker L., Hermann M., Cooper K.A., Serafini M., Luscher T.F., Ruschitzka F., Noll G., et al. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 2007, 116:2376-2382.